Karl K. Email & Phone Number

HCELL GRANTED ORPHAN DRUG DESIGNATION FROM THE U.S. FDA FOR HC017AA ALOPECIA AREATA IN THE PEDIATRIC POPULATIONHCell Inc., a privately held biotechnology company based in Austin, Texas, focusing on Alopecia Areata in the Pediatric Population, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to HC017AA for the treatment of pediatric patients with alopecia areata, a devastating hair loss disease.The FDA grants Orphan Drug Designation status to drugs and biologics that treat rare diseases, which is defined as those affecting fewer than 200,000 people, in the U.S. The FDA Office of Orphan Products Development evaluates scientific and clinical data submissions from sponsors to identify and designate products as promising for rare diseases and to advance scientific development of such promising medical products. HCell Inc. is also working on initiating regulatory steps for HC0100, which comprises proprietary composition and procedure for the treatment of Androgenic Alopecia conditions in both men and women. Further, HCell Inc. is planning pre-clinical development with the intent to launch a human clinical study in the U.S.In business where “getting it done right the first time” is the rule not an exception, Karl Kim functions in the role of Chief Operating Officer at HCell, Inc. Highly regarded for his business process acumen, innovation, creativity and execution, Karl has led projects that have won numerous awards including the Clio Award, Business Week IDSA Awards, New Media Invision Awards, I.D. Magazine Interactive Media Awards, and Industries-Forum Hannover Interactive Awards.Specialties: Expert in business process management, innovations and strategies; Expert knowledge of Theoretical Design encompassing Usability, Human Factors, Cognitive Ergonomics and HMI/HCI, Information Architecture; Social Media & Contextual Marketing; Agile Software Development.

Listed skills include Returns, Consulting, Market, Ease, and 230 others.

• 

  The University Of Texas At Austin